EMPACON MET 5/500 TABLET

Product Description

EMPACON MET 5/500 TABLET
Empagliflozin 5 mg + Metformin Hydrochloride 500 mg

Product Description:

EMPACON MET 5/500 TABLET is a high-quality oral antidiabetic medication formulated with Empagliflozin 5 mg and Metformin Hydrochloride 500 mg, designed to provide effective glycemic control in patients with Type 2 Diabetes Mellitus. Manufactured under strict pharmaceutical standards, this combination therapy supports improved insulin sensitivity, reduced glucose absorption, and enhanced urinary glucose excretion.

Key Benefits:

• Dual-action formula for optimal blood sugar management

• Helps reduce HbA1c levels and improve metabolic outcomes

• Supports weight control and cardiovascular health in diabetic patients

• Convenient once/twice daily dosing enhances patient compliance

Usage/Application:
Recommended as part of a comprehensive diabetes management plan including diet and exercise, EMPACON MET 5/500 TABLET is suitable for adult patients requiring combination therapy for improved glycemic control.

Composition:

• Empagliflozin 5 mg

• Metformin Hydrochloride 500 mg

• Excipients q.s.

• Colour: Approved colour used

Target Buyers:
Ideal for pharmaceutical distributors, hospital supply chains, diabetic care retailers, and bulk medicine buyers looking for trusted, efficacious diabetes control formulations.

Availability:
Ready for bulk orders, private labeling, and distributor partnerships across India and global export markets.